Seminar - Dr. Albert Berghuis
Dr. Albert Berghuis
MBIM Seminar Series
Starts
Jun 04, 2024 - 12:30 pmAdd to Calendar 2024-06-04 19:30:00 2024-06-04 19:30:00 Seminar - Dr. Albert Berghuis

Seminar: Antibiotic Resistance up close: a structural biology perspective on a global health threat

 

Abstract: The dangers antibiotic resistance poses to human health needs little introduction. Statistics, such as that more than one million deaths annually are directly attributable to resistant bacteria, have been well publicized. The WHO has advocated a multi-pronged approach to address this global heath threat, which includes developing new medicines. We have used structural biological approaches to examine various mechanisms of antibiotic resistance, with the objective of informing the development of new therapeutic options. Notably, we have examined enzyme-mediated resistance to aminoglycoside and macrolide antibiotics. Our findings have underscored the difficulties of drug development in the contexts of wide-spread multi-drug resistance, but have also revealed viable avenues to combat resistance.

LSC 3 (Life Sciences Institute - 2350 Health Sciences Mall) MBIM itsupport@microbiology.ubc.ca America/Vancouver public
Ends
Jun 04, 2024 - 1:30 pm
Location
LSC 3 (Life Sciences Institute - 2350 Health Sciences Mall)
Presenter title
Distinguished James McGill Professor, Departments of Biochemistry and Microbiology & Immunology, McGill University
Presenter name
Dr. Albert Berghuis

Seminar: Antibiotic Resistance up close: a structural biology perspective on a global health threat

 

Abstract: The dangers antibiotic resistance poses to human health needs little introduction. Statistics, such as that more than one million deaths annually are directly attributable to resistant bacteria, have been well publicized. The WHO has advocated a multi-pronged approach to address this global heath threat, which includes developing new medicines. We have used structural biological approaches to examine various mechanisms of antibiotic resistance, with the objective of informing the development of new therapeutic options. Notably, we have examined enzyme-mediated resistance to aminoglycoside and macrolide antibiotics. Our findings have underscored the difficulties of drug development in the contexts of wide-spread multi-drug resistance, but have also revealed viable avenues to combat resistance.